0 Commentaires
0 Parts
704 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
CAR-NK Cell Therapy Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033" According to the latest report published by Data Bridge Market Research, the CAR-NK Cell Therapy Market The global CAR-NK cell therapy market size was valued at USD 346.5 Million in 2025 and is expected to reach USD 1,004.50 Million by 2033, at a CAGR of 14.20% during the forecast period The market growth is largely fueled by increasing investments in...0 Commentaires 0 Parts 90 Vue 0 Aperçu
-
CAR-T Cell Therapy Market Driven by Growing Demand for Targeted ImmunotherapiesThe global oncology industry is rapidly transforming with the adoption of advanced immunotherapy solutions, making the CAR-T Cell Therapy Market one of the fastest-growing sectors in cancer treatment. Chimeric antigen receptor T-cell therapies are revolutionizing the treatment landscape for hematologic malignancies by utilizing genetically modified T cells to target and destroy cancer cells....0 Commentaires 0 Parts 400 Vue 0 Aperçu
-
CAR-T Cell Therapy Market Share Increasing with Growing Adoption of Personalized Cancer TreatmentsThe global orthopedic sector is witnessing substantial growth with increasing adoption of advanced hip replacement technologies, making the Acetabular Prostheses Market a critical segment within orthopedic implant solutions. Acetabular prostheses are extensively used during hip replacement surgeries to restore mobility, reduce chronic pain, and improve overall quality of life for patients...0 Commentaires 0 Parts 634 Vue 0 Aperçu
-
China Immunotherapy Drugs Market: How Is CAR-T Cell Therapy Developing in China?China CAR-T cell therapy market — the rapidly developing cellular immunotherapy sector in China encompassing both approved CAR-T products and the world's most extensive CAR-T clinical trial pipeline — creates a distinct and commercially significant segment within the Chinese immunotherapy market, with the China Immunotherapy Drugs Market reflecting CAR-T therapy as the most...0 Commentaires 0 Parts 742 Vue 0 Aperçu
-
Global CAR-NK Cell Therapy Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033The global CAR-NK cell therapy market size was valued at USD 346.5 Million in 2025 and is expected to reach USD 1,004.50 Million by 2033, at a CAGR of 14.20% during the forecast period The market growth is largely fueled by increasing investments in advanced immunotherapies, rising prevalence of cancer, and continuous technological progress in genetic engineering...0 Commentaires 0 Parts 159 Vue 0 Aperçu
-
Rising Investments in Cancer Research Supporting CAR-T Cell Therapy Market Growth WorldwideThe global oncology industry is rapidly transforming with the adoption of advanced immunotherapy solutions, making the CAR-T Cell Therapy Market one of the fastest-growing sectors in cancer treatment. Chimeric antigen receptor T-cell therapies are revolutionizing the treatment landscape for hematologic malignancies by utilizing genetically modified T cells to target and destroy cancer cells....0 Commentaires 0 Parts 486 Vue 0 Aperçu
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. A team involved in preparing this Blood Cancer Market research report has kept certain things into...0 Commentaires 0 Parts 623 Vue 0 Aperçu
-
CAR T-Cell Therapy & Immune Checkpoint InhibitorsTwo of the most transformative advances in modern oncology are CAR T-Cell Therapy and Immune Checkpoint Inhibitors. Both harness the immune system to fight cancer, but they do so through fundamentally different mechanisms. Checkpoint inhibitors are off-the-shelf antibodies that release the brakes on the immune system, enabling pre-existing T cells to attack tumors. CAR T-cell...0 Commentaires 0 Parts 377 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek